Trial intelligence / Profile preview

Estradiol Vaginal Tablets vs Promestriene Cream for Vulvovaginal Atrophy

NCT04232813Phase 3Completed

Sponsor
Instituto Palacios
Start
Jan 2020
Primary completion
Jun 2020
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 3 trial of estradiol in Vulvovaginal atrophy (VVA), sponsored by Instituto Palacios. Started Jan 2020; status: completed.

02

Drugs

estradiol
03

Conditions

Vulvovaginal atrophy (VVA)

Beyond the preview

Go deeper on NCT04232813.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04232813.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call